Immunoassay Market
Growing incidence of chronic and infectious diseases is anticipated to fuel demand for immunoassay. For example, as per a report published by the World Health Organization (WHO), in 2017, approximately 65 million individuals in the U.S. were diagnosed with Chronic Obstructive Pulmonary Disease (COPD). The factor is likely to boost regional immunoassay market.
Meanwhile, growing geriatric population across the world is anticipated to be a key driving factor for immunoassay market at global level. Owing to low immunity factor associated with old age, elderly population is more susceptible to chronic diseases and various infections.
Thus, most of diseases among arthritis, hypertension, diabetes, and dementia among others are diagnosed in elderly population.
For example, as per a report published by the United Nations, in 2017, the count of geriatric population was 962 million worldwide. The count is estimated to reach 2.1 billion by the end of 2050. This, in turn, is likely to pave potential opportunities for growth of the global immunoassay market.
Further, growing incidence of infectious diseases such as hepatitis, dengue, neurological disorders, and AIDS is a prominent factor projected to present tremendous opportunities for growth of immunoassay market over the forecast period (2018-2026).
For example, in 2017, as per data given by the WHO, approximately 5.8 million cases of severe dengue were identifies in Americans.
Rise in prevalence of such diseases is likely to provide lucrative opportunities for the prominent market players. In order to speed-up the diagnosis process, the companies operating in the global immunoassay market are focusing on development of novel immunoassay products.
The growth of the global immunoassay market largely depends on advancements in medical treatments and therapies. The healthcare industry is following a multifaceted route to cure and immunize patients against widespread infections and diseases. It is important for medical practitioners to understand the root causes of an infection in order to administer the right treatment line. Several diseases are related to the biochemical reactions going on inside the human body. Furthermore, the development of a seamless medical industry also calls for the study of biochemical reactions in the human body. There has been an increase in the incidence of infectious diseases in recent times. Medical practitioners mandate the use of macromolecular tests to understand the nature and type of disease or infection. The use of antibodies and antigens to conduct immunoassays has helped in increasing the rate of diagnosis across the medical and healthcare fraternities.
In this review, Transparency Market Research (TMR) uncovers a range of factors responsible for the growth and expansion of the global immunoassay market. The review elucidates the applications of immunoassays in key healthcare domains, creating new opportunities for market expansion. Furthermore, the segments pertaining to the immunoassay market have also been enunciated herein. It is worthwhile to understand that immunoassays can be used in various medical and healthcare verticals depending upon the type of requirement. Use of analytes, antigens, and antibodies for immunoassays has generated humongous opportunities the market players. The need for studying and quantifying analytes present in biological liquid samples such as urine or serum is felt across key domains. Immunoassays can help in achieving the aforementioned goal. The growth of the medical research fraternity across several regions shall be a launch pad for revenue generation across the market.
Use of Multiple Types of Immunoassay Markers
Medical practitioners study body proteins to analyse the reasons and causes behind the occurrence of a particular medical condition. Furthermore, the molecular composition of the human body is also analysed before administering a treatment line for critical infections. Several kinds of proteins and macromolecules can be studied through immunoassays. This factor has generated humongous opportunities for growth and expansion within the global immunoassay market. Medical professionals use several types of immunoassays that come in different formats. These immunoassays can be blended with certain reagents in order to enhance the performance of the former. Heterogeneous immunoassays have gained popularity across the medical industry. Physical measurements pertaining to immunoassays are under review, and favourable results could contribute to the growth of the market. The medical research industry is continually scouting for new technologies that can help in improving the performance of immunoassays. The application of protein-analysis in key domains within healthcare has played to the advantage of the immunoassay market.
Use of Immunoassays for Clinical Tests and Key Treatment Lines
The detection of analytes through immunoassays has helped the medical industry in fostering quality across primary treatment lines. Several types of clinical tests involve the use of immunoassay techniques, also known as immunodiagnostic tests. The use of immunoassays for pregnancy detection at home has emerged as an important driver of demand within the global market. Until a decade ago, there was widespread contention related to the accuracy of immunoassay tests. However, in recent times, the medical fraternity has acknowledged the use of immunoassay as medical markers. The use of immunoassay to measure insulin levels and diagnose heart diseases has also gained momentum in recent times. A number of pharmaceutical entities and research labs use immunoassay to test key compounds. On account of the factors mentioned herein, it is legit to expect that the global immunoassay market would grow at a sturdy pace in the times to follow.
Rising Incidence of Various Forms of Cancers
The use of immunoassays for diagnosing cancers has emerged as a vital driver of demand within the global market. The high incidence of cancer across several regional pockets has raised concerns across medical circles. Use of immunoassay for diagnosing prostate cancer has increased, mainly due to the ease of assessing prostate-specific antigens and hypoglycaemia through immunoassays. Over the course of the next decade, the total volume of revenues within the global immunoassay market is set to multiply. Assessment of heart disease can also be done with the help of specialised immunoassays.
Anti-Doping Analysis for Sportspersons
Doping is a severe crime in the sports fraternity, and sportspersons are required to steer clear and clean of doping tests. The consumption of restricted drugs and power boosters for sportspersons follows from several rules and regulations. Therefore, it is important to set up anti-doping analysis laboratories to test samples of players. The use of recombinant human growth hormone can result in increased power and skill in sportspersons. Therefore, medical professionals use immunoassays for conducting anti-doping tests. The demand graph of the global immunoassay market is set to escalate in the times to follow. The popularity of photoacoustic immunoassays is set to given an impetus to market growth and maturity.
The leading vendors operating in the global immunoassay market are focusing on developing multiple-marker technologies. The development of customized immunoassays that can help in diagnosing cancers, heart diseases, and other problems shall help market players in capturing new markets. The relevance of immunoassays across multiple medical domains shall propel sales across the market. Some of the leading players operating in the global immunoassay market are Dickinson and Company, Abbott Laboratories, Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd., and Danaher Corporation.
The global Immunoassay market is segmented as follows:
|
Technology |
|
|
Product |
|
|
Application |
|
|
End-user |
|
|
Region |
|
Chapter 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary: Global Immunoassay Market
Chapter 4 Market Overview
4.1. Introduction
4.2. Key Industry Developments
Chapter 5 Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunities
5.4. Key Trends
5.5. Global Immunoassay Market Size (US$ Mn) Forecast, 2016–2026
5.6. Global Immunoassay Market Outlook
5.7. Industry Mergers & Acquisitions
5.8. Automate Immunoassay Analyzer Volume
5.9. Distributor Analysis
5.10. Regulatory Assessments, by Key Country/Region
5.11. Winning Imperatives
Chapter 6 Global Immunoassay Market Analysis and Forecast, by Technology
6.1. Key Findings
6.2. Introduction
6.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
6.3.1. Chemiluminescence Immunoassay (CLIA)
6.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
6.3.3. Enzyme-linked Fluorescent Assay (ELFA)
6.3.4. Radioimmunoassay (RIA)
6.3.5. Others ( Microarray, Immunofluorescence Assay Biochip Assay, Counting Immunoassay)
6.4. Market Attractiveness Analysis, by Technology
Chapter 7 Global Immunoassay Market Analysis and Forecast, by Product
7.1. Key Findings
7.2. Introduction
7.3. Market Size (US$ Mn) Forecast, by Product, 2018–2026
7.3.1. Analyzer
7.3.2. Consumables
7.4. Market Attractiveness Analysis, by Product
Chapter 8 Global Immunoassay Market Analysis and Forecast, by Application
8.1. Key Findings
8.2. Introduction
8.3. Market Size (US$ Mn) Forecast, by Application, 2018–2026
8.3.1. Infectious Disease
8.3.2. Endocrinology
8.3.3. Oncology
8.3.4. Cardiology
8.3.5. Orthopedics
8.3.6. Others (Autoimmune Disorders, Allergy, Therapeutic Drug Monitoring, Liver Diseases, Acid Base Tests, GI Stool Testing, etc.)
8.4. Market Attractiveness Analysis, by Application
Chapter 9 Global Immunoassay Market Analysis and Forecasts, by End-user
9.1. Key Findings
9.2. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
9.2.1. Hospitals and Diagnostics Laboratories
9.2.2. Blood Banks
9.2.3. Others (Academic & Research Institutes, Pharmaceutical & Biotech Companies)
9.3. Market Attractiveness Analysis, by End-user
Chapter 10 Global Immunoassay Market Analysis and Forecasts, by Region
10.1. Key Findings
10.2. Global Market Scenario
10.3. Market Value (US$ Mn) Forecast, by Region, 2018–2026
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
10.4. Market Attractiveness Analysis, by Region
10.5. Key Trends, by Region
Chapter 11 North America Immunoassay Market Analysis and Forecast
11.1. Market Overview
11.2. Market Size (US$ Mn) Forecast, by Country, 2018–2026
11.2.1. U.S.
11.2.2. Canada
11.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
11.3.1. Chemiluminescence Immunoassay (CLIA)
11.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
11.3.3. Enzyme Linked Fluorescent Assay (ELFA)
11.3.4. Radioimmunoassay (RIA)
11.3.5. Others
11.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
11.4.1. Analyzers
11.4.2. Consumables
11.5. Market Size (US$ Mn) Forecast, by Application, 2018–2026
11.5.1. Infectious Disease
11.5.2. Endocrinology
11.5.3. Oncology
11.5.4. Cardiology
11.5.5. Orthopedics
11.5.6. Others
11.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
11.6.1. Hospitals and Diagnostics Laboratories
11.6.2. Blood Banks
11.6.3. Others
11.7. Market Attractiveness Analysis
11.7.1. By Country
11.7.2. By Technology
11.7.3. By Product
11.7.4. By Application
11.7.5. By End-user
Chapter 12 Europe Immunoassay market Analysis and Forecast
12.1. Market Overview
12.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
12.2.1. U.K.
12.2.2. Germany
12.2.3. France
12.2.4. Italy
12.2.5. Spain
12.2.6. Rest of Europe
12.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
12.3.1. Chemiluminescence Immunoassay (CLIA)
12.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
12.3.3. Enzyme Linked Fluorescent Assay (ELFA)
12.3.4. Radioimmunoassay (RIA)
12.3.5. Others
12.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
12.4.1. Analyzers
12.4.2. Consumables
12.5. Market Size (US$ Mn) Forecast, by Application, 2018–2026
12.5.1. Infectious Disease
12.5.2. Endocrinology
12.5.3. Oncology
12.5.4. Cardiology
12.5.5. Orthopedics
12.5.6. Others
12.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
12.6.1. Hospitals and Diagnostics Laboratories
12.6.2. Blood Banks
12.6.3. Others
12.7. Market Attractiveness Analysis
12.7.1. By Country
12.7.2. By Technology
12.7.3. By Product
12.7.4. By Application
12.7.5. By End-user
Chapter 13 Asia Pacific Immunoassay Market Analysis and Forecast
13.1. Market Overview
13.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
13.2.1. China
13.2.2. India
13.2.3. Japan
13.2.4. Australia & New Zealand
13.2.5. Rest of Asia Pacific
13.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
13.3.1. Chemiluminescence Immunoassay (CLIA)
13.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
13.3.3. Enzyme Linked Fluorescent Assay (ELFA)
13.3.4. Radioimmunoassay (RIA)
13.3.5. Others
13.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
13.4.1. Analyzers
13.4.2. Consumables
13.5. Market Size (US$ Mn) Forecast, by Application, 2018–2026
13.5.1. Infectious Disease
13.5.2. Endocrinology
13.5.3. Oncology
13.5.4. Cardiology
13.5.5. Orthopedics
13.5.6. Others
13.6. Market size (US$ Mn) Forecast, by End-user, 2018–2026
13.6.1. Hospitals and Diagnostics Laboratories
13.6.2. Blood Banks
13.6.3. Others
13.7. Market Attractiveness Analysis
13.7.1. By Country
13.7.2. By Technology
13.7.3. By Product
13.7.4. By Application
13.7.5. By End-user
Chapter 14 Latin America Immunoassay Market Analysis and Forecast
14.1. Market Overview
14.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
14.2.1. Brazil
14.2.2. Mexico
14.2.3. Rest of Latin America
14.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
14.3.1. Chemiluminescence Immunoassay (CLIA)
14.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
14.3.3. Enzyme Linked Fluorescent Assay (ELFA)
14.3.4. Radioimmunoassay (RIA)
14.3.5. Others
14.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
14.4.1. Analyzers
14.4.2. Consumables
14.5. Market Size (US$ Mn) Forecast, by Application, 2018–2026
14.5.1. Infectious Disease
14.5.2. Endocrinology
14.5.3. Oncology
14.5.4. Cardiology
14.5.5. Orthopedics
14.5.6. Others
14.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
14.6.1. Hospitals and Diagnostics Laboratories
14.6.2. Blood Banks
14.6.3. Others
14.7. Market Attractiveness Analysis
14.7.1. By Country
14.7.2. By Technology
14.7.3. By Product
14.7.4. By Application
14.7.5. By End-user
Chapter 15 Middle East and Africa Immunoassay Market Analysis and Forecast
15.1. Market Overview
15.2. Market size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
15.2.1. GCC Countries
15.2.2. South Africa
15.2.3. Rest of Middle East and Africa
15.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
15.3.1. Chemiluminescence Immunoassay (CLIA)
15.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
15.3.3. Enzyme Linked Fluorescent Assay (ELFA)
15.3.4. Radioimmunoassay (RIA)
15.3.5. Others
15.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
15.4.1. Analyzers
15.4.2. Consumables
15.5. Market Size (US$ Mn) Forecast, by Application, 2018–2026
15.5.1. Infectious Disease
15.5.2. Endocrinology
15.5.3. Oncology
15.5.4. Cardiology
15.5.5. Orthopedics
15.5.6. Others
15.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
15.6.1. Hospitals and Diagnostics Laboratories
15.6.2. Blood Banks
15.6.3. Others
15.7. Market Attractiveness Analysis
15.7.1. By Country
15.7.2. By Technology
15.7.3. By Product
15.7.4. By Application
15.7.5. By End-user
Chapter 16 Competition Landscape
16.1. Global Immunoassay Market Share, by Company, 2017
16.2. Market Player – Competition Matrix (By Tier and Size of Companies)
16.3. Company Profiles
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Financial Overview
16.3.1.5. Strategic Overview
16.3.2. Danaher Corporation.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Financial Overview
16.3.2.5. Strategic Overview
16.3.3. Abbott Laboratories.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Financial Overview
16.3.3.5. Strategic Overview
16.3.4. Siemens Healthineers (Siemens AG)
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Financial Overview
16.3.4.5. Strategic Overview
16.3.5. DiaSorin S.p.A.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Financial Overview
16.3.5.5. Strategic Overview
16.3.6. Sysmex Corporation.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Financial Overview
16.3.6.5. Strategic Overview
16.3.7. bioMérieux SA
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Financial Overview
16.3.7.5. Strategic Overview
16.3.8. Ortho Clinical Diagnostics (a part of Carlyle Group).
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Financial Overview
16.3.8.5. Strategic Overview
16.3.9. Thermo Fisher Scientific, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Financial Overview
16.3.9.5. Strategic Overview
16.3.10. Becton, Dickinson and Company.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Financial Overview
16.3.10.5. Strategic Overview
16.3.11. Merck KGaA.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. SWOT Analysis
16.3.11.4. Financial Overview
16.3.11.5. Strategic Overview
List of Tables
Table 01: Global Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 02: Global Immunoassay Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 03: Global Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Immunoassay Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Immunoassay Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 08: North America Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 09: North America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 10: North America Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: U.S. Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 12: U.S. Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 13: U.S. Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 14: U.S. Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Canada Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 16: Canada Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 17: Canada Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Canada Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 19: Europe Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Europe Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 21: Europe Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Europe Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 23: Europe Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Germany Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 25: Germany Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 26: Germany Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 27: Germany Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 28: U.K. Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 29: U.K. Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 30: U.K. Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 31: U.K. Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 32: France Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 33: France Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 34: France Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 35: France Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 36: Italy Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 37: Italy Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 38: Italy Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 39: Italy Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 40: Spain Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 41: Spain Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 42: Spain Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 43: Spain Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 44: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 45: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 46: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 47: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 48: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 49: China Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 50: China Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 51: China Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 52: China Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 53: India Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 54: India Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 55: India Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 56: India Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 57: Japan Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 58: Japan Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 59: Japan Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 60: Japan Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 61: Australia & New Zealand Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 62: Australia & New Zealand Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 63: Australia & New Zealand Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 64: Australia & New Zealand Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 65: Latin America Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 66: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 67: Latin America Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 68: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 69: Latin America Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 70: Brazil Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 71: Brazil Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 72: Brazil Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 73: Brazil Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 74: Mexico Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 75: Mexico Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 76: Mexico Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 77: Mexico Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 78: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 79: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 80: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 81: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 82: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 83: GCC Countries Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 84: GCC Countries Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 85: GCC Countries Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 86: GCC Countries Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 87: South Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 88: South Africa Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 89: South Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 90: South Africa Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
List of Figures
Figure 01: Global Immunoassay Market Size (US$ Mn) Forecast, 2016–2026
Figure 03: Market Value Share, by Technology (2017)
Figure 04: Market Value Share, by Product (2017)
Figure 04: Market Value Share, by End-user (2017)
Figure 03: Market Value Share, by Application (2017)
Figure 04: Market Value Share, by Region (2017)
Figure 07: Global Immunoassay Market Value Share Analysis (US$ Mn), by Technology, 2017 and 2026
Figure 08: Global Immunoassay Market Attractiveness Analysis, by Technology, 2018–2026
Figure 09: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemiluminescence Immunoassay, 2016–2026
Figure 10: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enzyme-linked Immunosorbent Assay, 2016–2026
Figure 11: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enzyme Linked Fluorescent Assay, 2016–2026
Figure 12: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Radioimmunoassay, 2016–2026
Figure 13: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 14: Global Immunoassay Market Value Share Analysis (US$ Mn), by Product, 2017 and 2026
Figure 15: Global Immunoassay Market Attractiveness Analysis, by Product, 2018–2026
Figure 16: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzer, 2016–2026
Figure 17: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2016–2026
Figure 18: Global Immunoassay Market Value Share Analysis (US$ Mn), by Application, 2017 and 2026
Figure 19: Global Immunoassay Market Attractiveness Analysis, by Application, 2018–2026
Figure 20: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Infectious Disease, 2016–2026
Figure 21: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2015–2025
Figure 22: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2016–2026
Figure 23: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cardiology, 2016–2026
Figure 24: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Orthopedics, 2016–2026
Figure 25: Global Immunoassay Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 26: Global Immunoassay Market Value Share Analysis (US$ Mn), by End-user, 2017 and 2026
Figure 27: Global Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 28: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Diagnostic Laboratories, 2016–2026
Figure 29: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks, 2016–2026
Figure 30: Global Immunoassay Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 31: Global Immunoassay Market Value Share Analysis, by Region, 2017 and 2026
Figure 32: Global Immunoassay Market Attractiveness Analysis, by Region, 2018–2026
Figure 33: North America Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 34: North America Immunoassay Market Value Share Analysis (US$ Mn), by Country, 2017 and 2026
Figure 35: North America Immunoassay Market Attractiveness Analysis, by Country, 2018–2026
Figure 36: North America Immunoassay Market Value Share, by Technology, 2017 and 2025
Figure 37: North America Immunoassay Market Attractiveness, by Technology, 2018–2026
Figure 38: North America Immunoassay Market Value Share, by Product, 2017 and 2026
Figure 39: North America Immunoassay Market Attractiveness, by Product, 2018–2026
Figure 40: North America Immunoassay Market Value Share, by Application, 2017 and 2026
Figure 41: North America Immunoassay Market Attractiveness, by Application, 2018–2026
Figure 42: North America Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
Figure 43: North America Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 44: Europe Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 45: Europe Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
Figure 46: Europe Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 47: Europe Immunoassay Market Value Share, by Technology, 2017 and 2025
Figure 48: Europe Immunoassay Market Attractiveness, by Technology, 2018–2026
Figure 49: Europe Immunoassay Market Value Share, by Product, 2017 and 2026
Figure 50: Europe Immunoassay Market Attractiveness, by Product, 2018–2026
Figure 51: Europe Immunoassay Market Value Share, by Application, 2017 and 2026
Figure 52: Europe Immunoassay Market Attractiveness, by Application, 2018–2026
Figure 53: Europe Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
Figure 54: Europe Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 55: Asia Pacific Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 56: Asia Pacific Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
Figure 57: Asia Pacific Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 58: Asia Pacific Immunoassay Market Value Share, by Technology, 2017 and 2025
Figure 59: Asia Pacific Immunoassay Market Attractiveness, by Technology, 2018–2026
Figure 60: Asia Pacific Immunoassay Market Value Share, by Product, 2017 and 2026
Figure 61: Asia Pacific Immunoassay Market Attractiveness, by Product, 2018–2026
Figure 62: Asia Pacific Immunoassay Market Value Share, by Application, 2017 and 2026
Figure 63: Asia Pacific Immunoassay Market Attractiveness, by Application, 2018–2026
Figure 64: Asia Pacific Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
Figure 65: Asia Pacific Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 66: Latin America Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 67: Latin America Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
Figure 68: Latin America Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 69: Latin America Immunoassay Market Value Share, by Technology, 2017 and 2025
Figure 70: Latin America Immunoassay Market Attractiveness, by Technology, 2018–2026
Figure 71: Latin America Immunoassay Market Value Share, by Product, 2017 and 2026
Figure 72: Latin America Immunoassay Market Attractiveness, by Product, 2018–2026
Figure 73: Latin America Immunoassay Market Value Share, by Application, 2017 and 2026
Figure 74: Latin America Immunoassay Market Attractiveness, by Application, 2018–2026
Figure 75: Latin America Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
Figure 76: Latin America Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 77: Middle East & Africa Immunoassay Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 78: Middle East & Africa Immunoassay Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2017 and 2026
Figure 79: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 80: Middle East & Africa Immunoassay Market Value Share, by Technology, 2017 and 2025
Figure 81: Middle East & Africa Immunoassay Market Attractiveness, by Technology, 2018–2026
Figure 82: Middle East & Africa Immunoassay Market Value Share, by Product, 2017 and 2026
Figure 83: Middle East & Africa Immunoassay Market Attractiveness, by Product, 2018–2026
Figure 84: Middle East & Africa Immunoassay Market Value Share, by Application, 2017 and 2026
Figure 85: Middle East & Africa Immunoassay Market Attractiveness, by Application, 2018–2026
Figure 86: Middle East & Africa Immunoassay Market Value Share Analysis, by End-user, 2017 and 2026
Figure 87: Middle East & Africa Immunoassay Market Attractiveness Analysis, by End-user, 2018–2026
Figure 88: Global Immunoassay Market Share Analysis, by Company (2017)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes